who knows - but obviously a stupid decision. I think with all the Covid delays with trial enrollment they were just keen to have 1 trial group enrolled and completed.
OPT Price at posting:
60.0¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.